These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2066638)

  • 21. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic renal damage caused by cyclosporine.
    Simpson JG; Saunders NJ; Thomson KJ; Whiting PH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):792-9. PubMed ID: 3388514
    [No Abstract]   [Full Text] [Related]  

  • 26. Alterations in proteolytic enzymes of the proximal tubule in a rat model of cyclosporine nephrotoxicity.
    Olbricht CJ; Gröne HJ; Bossaller C; Gutjahr E; Hertel RF
    Transplantation; 1990 Sep; 50(3):378-81. PubMed ID: 2402785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture study.
    Dieperink H; Starklint H; Leyssac PP; Kemp E
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():853-9. PubMed ID: 3991583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal hemodynamics in rats with cadmium-induced nephropathy.
    Uriu K; Kaizu K; Komine N; Ikeda M; Qie YL; Hashimoto O; Matsuoka A; Eto S
    Toxicol Appl Pharmacol; 1998 May; 150(1):76-85. PubMed ID: 9630455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and biochemical observations in rat nephron epithelia following cyclosporine A (CsA) treatment.
    Pfaller W; Kotanko P; Bazzanella A
    Clin Nephrol; 1986; 25 Suppl 1():S105-10. PubMed ID: 3011336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity.
    Whiting PH; Propper DJ; Simpson JG; McKay J; Jones MC; Catto GR
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):675-80. PubMed ID: 3388506
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of Nva2-cyclosporine on glomerular filtration rate and renal blood flow in the rat.
    Paller MS; Ferris TF
    Transplantation; 1987 Jun; 43(6):893-5. PubMed ID: 3590301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
    Obatomi DK; Bach PH
    In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
    Ryffel B; Donatsch P; Hiestand P; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S95-9. PubMed ID: 3458551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine A nephrotoxicity in Goldblatt renovascular hypertension in rats.
    Thiel G; Mihatsch MJ; Stahl RA; Hermle M; Brunner FP
    Clin Nephrol; 1986; 25 Suppl 1():S199-204. PubMed ID: 3519027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mannitol potentiates cyclosporine nephrotoxicity.
    Brunner FP; Hermle M; Mihatsch MJ; Thiel G
    Clin Nephrol; 1986; 25 Suppl 1():S130-6. PubMed ID: 3086006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity.
    McAuley FT; Simpson JG; Thomson AW; Whiting PH
    Agents Actions; 1987 Jun; 21(1-2):209-16. PubMed ID: 3307341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity.
    Nielsen FT; Leyssac PP; Kemp E; Starklint H; Dieperink H
    Nephrol Dial Transplant; 1995; 10(3):334-40. PubMed ID: 7540737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicity of cyclosporine A in the rat. II. Reversible changes in intranephronal and urinary catalytic activities of N-acetyl-beta-D-glucosaminidase.
    Schmid H; Lindmeier I; Schmitt H; Eissele R; Neuhaus G; Wehrmann M
    Ren Physiol Biochem; 1993; 16(4):222-32. PubMed ID: 7689244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental cyclosporin A nephrotoxicity.
    Whiting PH; Thomson AW; Blair JT; Simpson JG
    Br J Exp Pathol; 1982 Feb; 63(1):88-94. PubMed ID: 7066186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.